Arkolith/Insider Trading/BNTC/Form 4

Boston Megan

Executive Director, DirectorBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Aug 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Buy(P)26K——26K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2023Buy(P)26K——26K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-018119) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML